Mycobacteriosis, which encompasses tuberculosis, leprae and nontuberculous mycobacteriosis, presents significant challenges ...

Thousands of women in England will now be able to access the morning after pill for free from pharmacies, as part of the ...

Researchers have just identified a powerful new antibiotic – in a significant discovery made not by breaking new ground, but ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...

A team of scientists discovered a hidden antibiotic 100 times stronger than existing drugs against deadly superbugs like MRSA. The molecule had been overlooked for decades in a familiar bacterium. It ...

Existing methods for antibiotic selection are based on outdated and inaccurate microbiological principles, causing millions of inappropriate antibiotic selections and hundreds of thousands of ...

A potent new antibiotic intermediate from Streptomyces coelicolor is 100 times stronger than methylenomycin A against drug-resistant bacteria.

Chemists from the university, along with a team from Monash University, Australia, said the compound, called ...

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s ...

AstraZeneca and Amgen have received U.S. Food and Drug Administration (FDA) approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance treatment for adults and adolescents aged 12 and ...